These agents, Abacavir Sulfate, Abarelix, and Abiraterone Acetate, each possess unique chemical organizations leading to their varying pharmacological actions. Abacavir Sulfate, a nucleoside reverse transcriptase inhibitor, is readily detected via its molecular formula – C14H15N6O4·H2SO4 – and characteristic luminescent properties observed in techniques such as mass spectrometry and infrared analysis. Abarelix, a gonadotropin-releasing hormone (GnRH) receptor antagonist, presents with a complex peptide sequence, typically requiring amino acid sequencing and peptide mapping for complete identification. Finally, Abiraterone Acetate, a CYP17 inhibitor utilized in prostate cancer treatment, can be verified through its precise mass and fragmentation patterns acquired through gas chromatography-mass spectrometry (GC-MS) alongside nuclear magnetic resonance (NMR) investigative data, ensuring its accurate chemical characterization.
Product: Abacavir Sulfate Sulfate (CAS 188062-50-2) & Related Materials
Explore the extensive product detailing Abacavir Disulfate Sulfate, identified by CAS number 188062-50-2, and a range of related compounds. Our provision includes multiple qualities to fulfill particular research and production demands. Discover detailed data including experimental information and existing containers options. Additionally, examine a selection of structurally similar substances that might be beneficial in the latest initiative. Our directory is structured to facilitate effective sourcing of premium research materials.
Drug Index: Abarelix and Abirateronum Acetate CAS Numbers
For researchers and medicinal professionals seeking precise drug identification, correct Chemical Abstract Service identifiers are crucial. Specifically, abarelix, a GnRH-releasing hormone antagonist used in managing prostate cancer, is assigned the Registry identifier 65572-21-8. Furthermore, AFLOQUALONE 56287-74-2 abiraterone acetate, a key medication in prostate disease, carries the Registry number 389292-17-3. Thorough recording and validation of these Chemical Abstract Service identifiers are imperative to verify correct compound assessment and related operations. These numbers are publicly obtainable through various research repositories. Frequently consult authorized data for the most details.
Drug Components: Abacavir Sulfate , , Abiraterone Acetate Acetate, CAS Listings
The recognition of essential pharmaceutical ingredients often relies on accurate chemical references. Notably, this piece quickly examines three important instances: Abacavir Sodium, a drug reverse enzyme inhibitor; Abarelix, a hormone antagonist; and Abiraterone, utilized in tumor management. Each compound is associated with a unique Registry number, supplying a consistent method for identifying details and ensuring precise exchange within the scientific industry. Consult the respective repositories for detailed entries and connected information.
Chemical Abstracts Service Number Database: Entries for Abacavir Sulfate, Abarelix, Abiraterone Acetate
The vast Chemical Abstracts Service (CAS) number is an critical resource for chemists and industry professionals alike. This piece briefly explores information pertaining to three important therapeutic compounds: Abacavir Sulfate Salt, a medication used to treat HIV; Abarelix Acetate, a antagonist used in treatment; and Abiraterone Acetate, a potent steroid biosynthesis inhibitor administered in the treatment of metastatic prostate cancer. Accessing the specific CAS number for each molecule allows for reliable identification and promotes correct literature retrieval. These individual identifiers are vital for compound accuracy and uniform documentation across the field.
Employing Application Programming Interface Material Data: Compound Identification with CAS Numbers
Accurate product recognition is critical in the material industry, and Application Programming Interface substance data provides a consistent solution. Specifically, Chemical Abstracts Service numbers act as distinct labels for substance entities, enabling seamless integration with collections and frameworks. This methodology also bolsters records accuracy but also streamlines procedures related to analysis, procurement, and compliance documentation. Additionally, obtaining this data via an Application Programming Interface promotes automation and reduces the risk for manual mistake.